IBP-9414 for the Prevention of Necrotizing Enterocolitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Necrotizing Enterocolitis

In brief

Two different dose levels will be evaluated in two different birth weight categories, compared to placebo with regards to safety and tolerability.

Key facts

Study ID
NCT02472769
Run by
Infant Bacterial Therapeutics
People needed
120
Starts
2016-05-27
Expected to finish
2017-08-07
Last updated by the study team
2017-12-29

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.